Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium
23 févr. 2023 07h00 HE
|
Theralase Technologies Inc.
TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
Clinical Research by Anderson Biotests, LLC, in Collaboration With the Bedford Research Foundation, Suggests New Paradigm for Determining Vasectomy Success
16 févr. 2023 09h00 HE
|
Anderson Biotests, LLC
BEDFORD, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Anderson Biotests, LLC, in collaboration with the Bedford Research Foundation (www.bedfordresearch.org), recently published results of analyses of...
Gemini partners with UroGPO, a Specialty Networks Company
18 janv. 2023 11h00 HE
|
Gemini Medical Technologies
Boca Raton, FL, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Gemini Medical Technologies, a privately held U.S.-based urodynamics diagnostics manufacturer, announced a new partnership today with UroGPO, a...
Global Urology and Pelvic Health Market is anticipated to witness a healthy growth rate of 8% from 2022 to 2027
17 janv. 2023 09h30 HE
|
Medi-Tech Insights
BRUSSELS, BELGIUM, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Description: Urology and pelvic health is a medical and surgical specialty involving disorders of the genitourinary tract and the adrenal...
Urology Devices Market Size to Hit USD 48.4 Billion by 2030 at 4% CAGR – Report by Market Research Future (MRFR)
23 nov. 2022 10h30 HE
|
Market Research Future
New York, USA, Nov. 23, 2022 (GLOBE NEWSWIRE) -- According to a Comprehensive Research Report by Market Research Future (MRFR), Urology Devices Market Information By Types, Technology, Applications,...
Sonomotion Raises USD$12.4 Million in Series C Funding to Advance Development of Break Wave
17 nov. 2022 05h30 HE
|
Advanced MedTech
San Francisco and Singapore, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Funds raised will support SonoMotion’s upcoming pivotal, international, multicenter clinical trial of the Break WaveTM...
Coloplast udnævner ny chef for den globale urologiforretning
15 nov. 2022 10h00 HE
|
Coloplast A/S
Den 2. januar 2023 overtager Tommy Johns stillingen som ansvarlig for Coloplasts globale urologiforretning. Tommy Johns tager over efter Steve Blum, der har besluttet at gå på pension ved dette års...
Coloplast appoints new President of its global Interventional Urology business
15 nov. 2022 10h00 HE
|
Coloplast A/S
Effective January 2, 2023, Tommy Johns will enter a new role as President & Senior Vice President of Coloplast’s global Interventional Urology (IU) business, replacing Steve Blum, who has decided...
InterMed Resources and UroViu Corp Announce Agreement With HealthTrust Purchasing Group
10 nov. 2022 09h00 HE
|
UroViu Corp
LOS ALTOS, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- InterMed Resources Tennessee and UroViu Corp, a company that develops and commercializes highly portable single-use endoscopy platforms,...
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information
10 nov. 2022 08h00 HE
|
Myriad Genetics, Inc.
UroSuite helps healthcare providers personalize treatment with easier access to biomarker, germline and somatic testing from a single source. SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) --...